Development of an artificial intelligence algorithm for adjuvant chemotherapy based on a nationwide registry of patients with gastric cancer by the Japanese Gastric Cancer Association (JGCA).

Authors

null

Yasuhide Yamada

National Center for Global Health and Medicine, Tokyo, Japan

Yasuhide Yamada , Ami Kamada , Yoshinori Kabeya , Sumito Yoshida , Hitoshi Harada , Naoki Urakawa , Shingo Kanaji , Yuma Nakamura , Kengo Nagashima , HIROYA TAKEUCHI , Yuichiro Doki , Yuko Kitagawa , Yasuhiro Kodera , Yoshihiro Kakeji

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 4063)

DOI

10.1200/JCO.2023.41.16_suppl.4063

Abstract #

4063

Poster Bd #

384

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

A phase II trial of CapeOX plus nivolumab for early relapsed HER2-negative gastric cancer (JACCRO GC-11: FirSTAR trial).

First Author: Hiroyuki Arai

Poster

2023 ASCO Gastrointestinal Cancers Symposium

Adjuvant chemotherapy for older patients with stage II/III gastric cancer: A retrospective cohort study.

Adjuvant chemotherapy for older patients with stage II/III gastric cancer: A retrospective cohort study.

First Author: Yu-Hsuan Shih

First Author: Souya Nunobe